Showing 1 - 14 results of 14 for search 'T. Henrik Anderson Tvedt', query time: 0.06s
Refine Results
-
1
Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia—Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell Transp... by Øystein Bruserud, Galina Tsykunova, Maria Hernandez-Valladares, Hakon Reikvam, Tor Henrik Anderson Tvedt
Published 2021-05-01
Article -
2
P969: VRD OUTPERFORMED VCD AS INDUCTION THERAPY BEFORE FIRST-LINE ASCT IN MULITPLE MYELOMA; RESULTS FROM A NATIONWIDE, POPULATION-BASED STUDY by Jakob Nordberg Nørgaard, Kari Lenita Falck Moore, Tobias Slørdahl, Anders Vik, Tor Henrik Anderson Tvedt, Fredrik Schjesvold
Published 2023-08-01
Article -
3
VRD versus VCD as induction therapy before autologous stem cell transplantation in multiple myeloma: a nationwide population-based study by Jakob Nordberg Nørgaard, Kari Lenita Falck Moore, Tobias S. Slørdahl, Anders Vik, Tor Henrik Anderson Tvedt, Fredrik Schjesvold
Published 2024-04-01
Article -
4
The Acute Phase Reaction and Its Prognostic Impact in Patients with Head and Neck Squamous Cell Carcinoma: Single Biomarkers Including C-Reactive Protein Versus Biomarker Profiles by Helene Hersvik Aarstad, Svein Erik Emblem Moe, Øystein Bruserud, Stein Lybak, Hans Jørgen Aarstad, Tor Henrik Anderson Tvedt
Published 2020-10-01
Article -
5
Adult presentation of ornithine transcarbamylase deficiency: a possible cause of hyperammonemia after high-dose chemotherapy and stem cell transplantation by Galina Tsykunova, Erle Kristensen, Asbjørg Stray-Pedersen, Øyvind Bruserud, Ida Wiig Sørensen, Øystein Bruserud, Tor Henrik Anderson Tvedt
Published 2023-12-01
Article -
6
-
7
-
8
S304: SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, PROVIDES SUSTAINED IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): 2 YEAR FOLLOW-UP FROM THE... by A. Röth, C. M. Broome, W. Barcellini, T. Henrik Anderson Tvedt, Y. Miyakawa, S. D’Sa, D. Cella, F. Joly, J. Wang, T. Sourdille, F. Shafer, M. Wardęcki, I. C. Weitz
Published 2022-06-01
Article -
9
P1675: SUTIMLIMAB PROVIDES SUSTAINED IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: OPEN-LABEL EXTENSION OF THE PHASE 3 CAD... by Alexander Röth, Catherine M Broome, Wilma Barcellini, Bernd Jilma, Quentin A Hill, David Cella, Tor Henrik Anderson Tvedt, Masaki Yamaguchi, Irina Murakhovskaya, Michelle Lee, Frank Shafer, Marek Wardęcki, Deepthi Jayawardene, Ronnie Yoo, Jerome Msihid, Ilene C Weitz
Published 2023-08-01
Article -
10
Complement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results by Alexander Roth, Wilma Barcellini, Shirley D’Sa, Yoshitaka Miyakawa, Catherine M. Broome, Marc Michel, David J. Kuter, Bernd Jilma, Tor Henrik Anderson Tvedt, Ilene C. Weitz, Parija Patel, Xiaoyu Jiang, Caroline Reuter, Jun Su, Frank Shafer, Michelle Lee, Sigbjorn Berentsen
Published 2022-02-01
Article -
11
The function of the complement system remains fully intact throughout the course of allogeneic stem cell transplantation by Beatrice Fageräng, Beatrice Fageräng, Leon Cyranka, Camilla Schjalm, Karin Ekholt McAdam, Carina Sandem Larsen, Julia Heinzelbecker, Tobias Gedde-Dahl, Tobias Gedde-Dahl, Reinhard Würzner, Terje Espevik, Geir Erland Tjønnfjord, Geir Erland Tjønnfjord, Peter Garred, Andreas Barratt-Due, Tor Henrik Anderson Tvedt, Tom Eirik Mollnes, Tom Eirik Mollnes
Published 2024-06-01
Article -
12
Author Correction: Early response evaluation by single cell signaling profiling in acute myeloid leukemia by Benedicte Sjo Tislevoll, Monica Hellesøy, Oda Helen Eck Fagerholt, Stein-Erik Gullaksen, Aashish Srivastava, Even Birkeland, Dimitrios Kleftogiannis, Pilar Ayuda-Durán, Laure Piechaczyk, Dagim Shiferaw Tadele, Jørn Skavland, Panagotis Baliakas, Randi Hovland, Vibeke Andresen, Ole Morten Seternes, Tor Henrik Anderson Tvedt, Nima Aghaeepour, Sonia Gavasso, Kimmo Porkka, Inge Jonassen, Yngvar Fløisand, Jorrit Enserink, Nello Blaser, Bjørn Tore Gjertsen
Published 2023-03-01
Article -
13
Early response evaluation by single cell signaling profiling in acute myeloid leukemia by Benedicte Sjo Tislevoll, Monica Hellesøy, Oda Helen Eck Fagerholt, Stein-Erik Gullaksen, Aashish Srivastava, Even Birkeland, Dimitrios Kleftogiannis, Pilar Ayuda-Durán, Laure Piechaczyk, Dagim Shiferaw Tadele, Jørn Skavland, Panagotis Baliakas, Randi Hovland, Vibeke Andresen, Ole Morten Seternes, Tor Henrik Anderson Tvedt, Nima Aghaeepour, Sonia Gavasso, Kimmo Porkka, Inge Jonassen, Yngvar Fløisand, Jorrit Enserink, Nello Blaser, Bjørn Tore Gjertsen
Published 2023-01-01
Article -
14
Robust spike-specific CD4+ and CD8+ T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort study by Lorenzo Federico, Lorenzo Federico, Tor Henrik Anderson Tvedt, Murat Gainullin, Murat Gainullin, Julie Røkke Osen, Julie Røkke Osen, Viktoriia Chaban, Viktoriia Chaban, Katrine Persgård Lund, Katrine Persgård Lund, Lisa Tietze, Lisa Tietze, Trung The Tran, Trung The Tran, Fridtjof Lund-Johansen, Fridtjof Lund-Johansen, Hassen Kared, Hassen Kared, Andreas Lind, John Torgils Vaage, John Torgils Vaage, Richard Stratford, Simen Tennøe, Brandon Malone, Trevor Clancy, Anders Eivind Leren Myhre, Anders Eivind Leren Myhre, Tobias Gedde-Dahl, Ludvig André Munthe, Ludvig André Munthe
Published 2023-07-01
Article